KR

Krishna Ramkisan Tupe

Active Director Director DIN 10617399
DIN 10617399 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishna Ramkisan Tupe

Data last updated:

Krishna Ramkisan Tupe is a Director at Rx.Biozenic Pharma Private Limited (since 2024).

DIN 10617399
Primary Designation Director
First Appointment 04 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rx.Biozenic Pharma Private Limited U47721MH2024PTC424692
Director04 May 20242024Active

Board colleagues of Krishna Ramkisan Tupe

NameDINCompanyDesignation
Rameshwar Nivrutti Kendhale10617400Rx.Biozenic Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rx.Biozenic Pharma Private Limited
Premium access

Shareholding and investment profile for Krishna Ramkisan Tupe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishna Ramkisan Tupe

Krishna Ramkisan Tupe currently holds 1 directorship: Rx.Biozenic Pharma Private Limited (Director, since 04 May 2024).

Krishna Ramkisan Tupe was first appointed on 04 May 2024 as Director at Rx.Biozenic Pharma Private Limited.

The current boards of Krishna Ramkisan Tupe's companies include Rameshwar Nivrutti Kendhale (Rx.Biozenic Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available